DMII (Drugs Made In America Acquisition II) Other Operating Expense: $0.78 Mil (TTM As of Mar. 2026)


DMII Drugs Made In America Acquisition II Corp DMII
15 GF Score
Price $10.10
! 1 Warning Sign
View Full Analysis

What is Drugs Made In America Acquisition II Other Operating Expense?

Drugs Made In America Acquisition II DMII 15 Other Operating Expense is $0.78 Mil as of Mar. 2026. GuruFocus rates DMII with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Drugs Made In America Acquisition II's Other Operating Expense for the three months ended in Mar. 2026 was $-0.03 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $0.78 Mil.

Drugs Made In America Acquisition II's quarterly Other Operating Expense increased from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($0.81 Mil) but then declined from Dec. 2025 ($0.81 Mil) to Mar. 2026 ($-0.03 Mil).

Drugs Made In America Acquisition II's annual Other Operating Expense stayed the same from . 20 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then increased from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($0.81 Mil).

Drugs Made In America Acquisition II Other Operating Expense Related Terms

Drugs Made In America Acquisition II Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Drugs Made In America Acquisition II's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drugs Made In America Acquisition II Other Operating Expense Chart

Drugs Made In America Acquisition II Annual Data
Trend Dec24 Dec25
Other Operating Expense
0.00 0.81

Drugs Made In America Acquisition II Quarterly Data
Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial 0.00 0.00 0.00 0.81 -0.03
DMII
15GF Score
Drugs Made In America Acquisition II Corp DMII
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition II Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $0.78 Mil mean?
Drugs Made In America Acquisition II (DMII) has a Other Operating Expense of $0.78 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Drugs Made In America Acquisition II and its competitors.
Is Drugs Made In America Acquisition II's Other Operating Expense too high?
Drugs Made In America Acquisition II's current Other Operating Expense is $0.78 Mil. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's Other Operating Expense compare to BCSS and EVAC?
Drugs Made In America Acquisition II's Other Operating Expense of $0.78 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Diversified Financial Services company?
A good Other Operating Expense depends on the Diversified Financial Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Drugs Made In America Acquisition II and its competitors. Drugs Made In America Acquisition II's current Other Operating Expense is $0.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current Other Operating Expense of $0.78 Mil. The current Other Operating Expense is $0.78 Mil. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current Other Operating Expense is $0.78 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
15GF Score

Get the complete analysis for DMII

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price